Department of Radiology, School of Medicine, Marmara University, Kayışdağı cad. Yayla Sokak, Mimoza Konutları No:41 A blok Daire:17, 34750 Küçükbakkalköy-Kadıköy, Istanbul, Turkey.
Department of Gastroenterology, School of Medicine, Marmara University, Istanbul, Turkey.
Abdom Radiol (NY). 2016 Aug;41(8):1505-10. doi: 10.1007/s00261-016-0699-6.
Liver fibrosis is an important prognostic determinant in patients with nonalcoholic steatohepatitis (NASH). Hepatic artery resistivity index (HARI) is a doppler ultrasonography (US) parameter that is used to follow up microcirculatory resistance in fatty liver. We aimed to asses whether it is possible to demonstrate significant fibrosis by means of doppler US in comparison with transient elastography (TE) and liver biopsy in NASH patients.
A total of 63 (mean age 47.1 ± 8.4 years, 39 male, 24 female) biopsy-proven NASH patients were enrolled in this prospective study. The study population was classified into two groups: significant and no-significant fibrosis patients. Doppler US and TE were performed in two groups.
HARI and TE values were significantly higher in significant fibrosis group (0.81 ± 0.05 vs. 0.63 ± 0.14, p < 0.0005; 15.9 ± 4.8 vs. 6.2 ± 2.6 kilopascals, p < 0.0005; respectively). Based on the ROC curve, the optimal cut-off value of HARI for a significant fibrosis was >0.75, which yielded a sensitivity of 78% and a specificity of 75%, with the area under the curve at 0.90. The optimal cut-off value of TE for a significant fibrosis was >9.8 kilopascals, which yielded a sensitivity of 90% and a specificity of 91%, with the area under the curve at 0.95. HARI values were moderately correlated with TE values (r = 0.53, p < 0.001).
Doppler US has moderate % sensitivity and % specificity, which is lower compared with TE for the diagnosis significant fibrosis. However, it may be used as an alternative method for the assessment of fibrosis in patients with NASH who are not good candidates for TE evaluation.
肝纤维化是非酒精性脂肪性肝炎(NASH)患者的重要预后决定因素。肝动脉阻力指数(HARI)是一种多普勒超声(US)参数,用于随访脂肪肝的微循环阻力。我们旨在通过多普勒 US 评估与瞬时弹性成像(TE)和肝活检相比,其是否可在 NASH 患者中显示出显著纤维化。
这项前瞻性研究共纳入 63 例(平均年龄 47.1 ± 8.4 岁,39 名男性,24 名女性)经活检证实的 NASH 患者。该研究人群分为两组:有显著纤维化和无显著纤维化患者。在两组患者中均进行多普勒 US 和 TE 检查。
HARI 和 TE 值在有显著纤维化组中明显更高(0.81 ± 0.05 比 0.63 ± 0.14,p < 0.0005;15.9 ± 4.8 比 6.2 ± 2.6 千帕斯卡,p < 0.0005;分别)。基于 ROC 曲线,HARI 用于显著纤维化的最佳截断值为 >0.75,其敏感性为 78%,特异性为 75%,曲线下面积为 0.90。TE 用于显著纤维化的最佳截断值为 >9.8 千帕斯卡,其敏感性为 90%,特异性为 91%,曲线下面积为 0.95。HARI 值与 TE 值中度相关(r = 0.53,p < 0.001)。
与 TE 相比,多普勒 US 诊断显著纤维化的敏感性和特异性中等,较低。然而,对于不适合 TE 评估的 NASH 患者,它可以作为纤维化评估的替代方法。